J. Baak

P. V. van Diest, J. Baak, P. Kenemans, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression. Preliminary results.

P. V. van Diest, J. Baak, S. Bacus, 1992, Pathology, research and practice.

Correlation between morphometrical parameters and disease-free survival in ductal breast cancer treated only by surgery.

P. Barbini, J. Baak, P. Tosi, 1986, Applied pathology.

Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.

P. V. van Diest, J. Baak, S. Bacus, 1991, Laboratory investigation; a journal of technical methods and pathology.

Proliferation markers in tumours: interpretation and clinical value.

P. V. van Diest, G. Brugal, J. Baak, 1998, Journal of clinical pathology.

Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.

P. V. van Diest, J. Baak, E. Matze-Cok, 1991, Journal of clinical pathology.

The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands.

P. V. van Diest, W. Kwee, J. Baak, 1989, Pathology, research and practice.

Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the multicenter morphometric mammary carcinoma project (MMMCP)

P. V. van Diest, W. Kwee, H. Peterse, 1997, International journal of cancer.

Comparison of the prognostic value of mitotic frequency and Mitotic Activity Index in breast cancer

J. Baak, I. Jannink, P. Diest, 1996 .

Intratumor Heterogeneity of K-Ras and p53 Mutations among Human Colorectal Adenomas Containing Early Cancer

G. Meijer, J. Baak, M. Hermsen, 2000, Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology.

Microsatellite instability and DNA ploidy in colorectal cancer

K. Søreide, J. Baak, E. Janssen, 2009, Cancer.

Portal Chromosomal Instability in Pathogenesis and Prognosis of Colorectal Cancer

J. Schouten, M. Stolte, G. Meijer, 2010 .

The nuclei in cutaneous malignant melanoma, stage I, are smaller in survivors than in non-survivors.

P. Barbini, J. Smolle, J. Baak, 1989, Pathology, research and practice.

Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas

D. Pinkel, D. Albertson, A. Snijders, 2005, Oncogene.

Discriminant analysis, exemplified with quantitative features of endometrium.

J. Baak, P. Bezemer, C. de With, 1977, European journal of obstetrics, gynecology, and reproductive biology.

Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma

J. Baak, H. van der Putten, Ton Koenders, 1989, Cancer.

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

L. Akslen, J. Baak, E. Janssen, 2019, BMC Cancer.

Rapid and reliable assessment of volume percentage of epithelium in borderline and invasive ovarian tumors.

P. V. van Diest, G. Meijer, J. Baak, 1998, Analytical and quantitative cytology and histology.

Prognostic Proof and Possible Therapeutic Mechanisms of Herbal Medicine in Patients With Metastatic Lung and Colon Cancer

J. Baak, Luming Liu, K. Block, 2011, Integrative cancer therapies.

Traditional Chinese Medicine Herbal Treatment May Have a Relevant Impact on the Prognosis of Patients With Stage IV Adenocarcinoma of the Lung Treated With Platinum-Based Chemotherapy or Combined Targeted Therapy and Chemotherapy

J. Baak, Ling Xu, T. Madebo, 2011, Integrative cancer therapies.

Correlation between nuclear DNA content and steroid receptor status in ovarian cancer.

J. Baak, B. Slotman, B. Rao, 1991, European journal of obstetrics, gynecology, and reproductive biology.

Comparative Genomic Hybridization of Microdissected Familial Ovarian Carcinoma: Two Deleted Regions on Chromosome 15q Not Previously Identified in Sporadic Ovarian Carcinoma

A. Snijders, I. Jacobs, A. Ryan, 2001, Laboratory Investigation.

The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long‐term follow up

S. Wagenaar, J. Baak, N. Schipper, 1989, Cancer.

Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma.

J. Baak, G. Tan, 1984, Analytical and quantitative cytology.

Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics

J. Baak, P. Kenemans, M. Brinkhuis, 1995, International journal of cancer.

Prognostic value of morphometric features and the callender classification in uveal melanomas.

P. V. van Diest, J. Baak, J. Mullaney, 1996, Ophthalmology.

Quantitative Molecular Parameters to Identify Low-Risk and High-Risk Early CIN Lesions: Role of Markers of Proliferative Activity and Differentiation and Rb Availability

J. Baak, M. Arends, E. Janssen, 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Relationships between vascularization and proliferation in invasive breast cancer

P. V. van Diest, J. Baak, J. Beliën, 1999, The Journal of pathology.

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.

J. Baak, E. Janssen, I. Dalen, 2014, Human pathology.

Cervical precancer (intraepithelial neoplasia), including functional biomarkers and colposcopy

S. Robboy, S. Bean, M. Stoler, 2009 .

Quantitative Assessment of Gastric Antrum Atrophy Shows Restitution to Normal Histology after Helicobacter pylori Eradication

E. Kuipers, G. Meijer, E. Bloemena, 2004, Digestion.

Rapid quantitative assessment of gastric corpus atrophy in tissue sections

E. Kuipers, G. Meijer, E. Bloemena, 2001, Journal of clinical pathology.

Helicobacter pylori‐related and ‐non‐related gastric cancers do not differ with respect to chromosomal aberrations

E. Kuipers, G. Meijer, E. Bloemena, 2000, The Journal of pathology.

Objective Biomarkers in Endometrioid-Type Endometrial Carcinogenesis

P. Diest, J. Baak, P. Kenemans, 2005 .

Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast

W D Dupont, P. V. van Diest, P. V. van Diest, 2001, International journal of cancer.

Biomarkers of breast hyperplasias and in situ carcinomas: an overview.

P. V. van Diest, J. Baak, 1994, Journal of cellular biochemistry. Supplement.

Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast.

P. V. van Diest, C. Meijer, J. Baak, 1998, Human pathology.

From SELDI-TOF MS to protein identification by on-chip elution.

J. Baak, E. Janssen, O. Andersen, 2011, Journal of proteomics.

New chromosomal regions with high‐level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization

P. V. van Diest, G. Meijer, J. Baak, 2001, The Journal of pathology.

Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression

W. V. D. Van de Ven, J. Baak, E. Janssen, 2008, International journal of cancer.

Evaluation of 5 Different Labeled Polymer Immunohistochemical Detection Systems

J. Baak, E. Janssen, E. Gudlaugsson, 2010, Applied immunohistochemistry & molecular morphology : AIMM.

Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast

P. V. van Diest, C. Meijer, J. Baak, 1999 .

Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate

P. V. van Diest, J. Baak, J. D. de Jong, 2001, Breast Cancer Research and Treatment.

Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens.

P. V. van Diest, J. Baak, N. Schipper, 1990, Journal of clinical pathology.

Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients.

J. Baak, P. Kenemans, C. Burger, 1993, Cancer research.

Prognostic value of microvessel quantitation in cisplatin treated FIGO 3 and 4 ovarian cancer patients.

P. V. van Diest, J. Baak, J. P. Zevering, 1995, Pathology, research and practice.

Factors that influence persistence or recurrence of high-grade squamous intraepithelial lesion with positive margins after the loop electrosurgical excision procedure: a retrospective study

J. Baak, L. Sui, W. Feng, 2015, BMC Cancer.

Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.

J. Baak, L. Schuurmans, S. Makkink-Nombrado, 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Non‐random allelic losses at 3p, 11p and 13q during HPV‐mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes

C. Meijer, J. Walboomers, P. Snijders, 1998, International journal of cancer.

Estrogen receptors in human breast cancer

C. Meijer, M. Boon, J. Baak, 1982 .

Grading ovarian tumors. Evaluation of decision making by different pathologists.

A. Talerman, J. Baak, J. Delemarre, 1986, Analytical and quantitative cytology and histology.

The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract

J. Baak, P. Kenemans, C. Burger, 1993, International Journal of Gynecologic Cancer.

Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer

P. V. van Diest, J. Baak, P. Kenemans, 2002, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases.

J. Baak, P. Kenemans, C. Burger, 1992, European journal of cancer.

Prognostic value of proliferation and apoptosis in breast cancer

J. D. Jong, P. Diest, J. Baak, 2008 .

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study

T. Bathen, L. Akslen, J. Baak, 2019, BMC Cancer.

Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features. A case–control study

G. Meijer, I. Talbot, J. Baak, 1998, The Journal of pathology.

The prognostic variability of ovarian tumor grading by different pathologists.

A. Talerman, J. Baak, J. Delemarre, 1987, Gynecologic oncology.

Quantification of proliferative activity in colorectal adenomas by mitotic counts: relationship to degree of dysplasia and histological type.

G. Meijer, J. Baak, 1995, Journal of clinical pathology.

Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.

P. V. van Diest, C. Meijer, J. Baak, 1999, International journal of cancer.

Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

R. Golding, J. Baak, G. Teule, 1991, International Journal of Gynecologic Cancer.

Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus.

G. Meijer, J. Baak, J. V. van Lanschot, 1997, Analytical and quantitative cytology and histology.

Prognostic factors following enucleation of 111 uveal melanomas.

P. V. van Diest, J. Baak, M. Farrell, 1993, The British journal of ophthalmology.

Quantitative microscopical and confocal laser scanning microscopy for intermediate endpoint biomarkers in breast cancer: Potential and reproducibility

J. Baak, P. Tekola, J. Beliën, 1993, Journal of cellular biochemistry. Supplement.

The influence of fixatives and other variations in tissue processing on nuclear morphometric features.

J. Baak, E. Noteboom, J. J. Koevoets, 1989, Analytical and quantitative cytology and histology.

DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications.

J. Baak, E. Janssen, 2004, Histopathology.

Prognostic factors in borderline and invasive ovarian tumors of the common epithelial type.

J. Baak, P. Kenemans, J. Stolk, 1987, Pathology, Research and Practice.

Borderline ovarian tumors.

P. V. van Diest, J. Baak, 1998, The American journal of surgical pathology.

The prognostic value of morphometry in ovarian epithelial tumors of borderline malignancy.

H. Fox, J. Baak, C. H. Buckley, 1985 .

Benign endometrial hyperplasia and EIN

R. Bentley, S. Robboy, J. Baak, 2009 .

Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3

A. Malpica, J. Baak, E. Janssen, 2012, PloS one.

The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus

J. V. van Sandick, J. Baak, J. V. van Lanschot, 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Balance of cell proliferation and apoptosis in breast carcinogenesis

P. V. van Diest, C. Meijer, J. Baak, 1999, Breast Cancer Research and Treatment.

DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis.

P. V. van Diest, J. Baak, M. Leader, 1995, Human pathology.

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age

J. Baak, E. Janssen, E. Gudlaugsson, 2007, Modern Pathology.

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.

J. Peterse, P. V. van Diest, W. Kwee, 1992, Human pathology.

Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.

E. Kuipers, G. Meijer, E. Bloemena, 2001 .

Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study

E. Kuipers, G. Meijer, E. Bloemena, 2001, American Journal of Gastroenterology.

Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma

J. Baak, C. Miracco, P. Tosi, 1986, Cancer.

Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features

J. Baak, A. Smeulders, J. Lindeman, 1985, Histopathology.

Malignant brenner tumor: A histologic, morphometrical, immunohistochemical, and ultrastructural study

C. Meijer, J. Baak, C. Burger, 1986, Cancer.

The value of morphometry to classic prognosticators in breast cancer

J. Baak, J. Hermans, J P Baak, 1985, Cancer.

Prediction of Spontaneous Regression of Cervical Intraepithelial Neoplasia Lesions Grades 2 and 3 by Proteomic Analysis

J. Baak, E. Janssen, C. Brede, 2014, International journal of proteomics.

Fourth Updated ESACP Consensus Report on Diagnostic DNA Image Cytometry

G. Haroske, M. Oberholzer, F. Giroud, 2001, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

A protein profile study to discriminate CIN lesions from normal cervical epithelium

A. Malpica, J. Baak, E. Janssen, 2011, Cellular Oncology.

Morphometric definition and grading of gastric intestinal metaplasia

J. Baak, C. Miracco, T. Megha, 1990, The Journal of pathology.

Gastric dysplasia: A stereological and morphometrical assessment

P. Barbini, J. Baak, C. Miracco, 1987, The Journal of pathology.

Mitosis counting in tumors.

J. Baak, J P Baak, 1990, Human pathology.

Cell-cycle and Apoptosis Regulators (p16INK4A, p21CIP1, α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients

H. Körner, K. Søreide, J. Baak, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

P. V. van Diest, M. Hermsen, J. Walboomers, 1998, Journal of clinical pathology.

Genetic Alterations in Childhood Medulloblastoma Analyzed by Comparative Genomic Hybridization

F. Baas, P. Voûte, J. Baak, 2002, Journal of pediatric hematology/oncology.

Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.

J. Arends, G. Meijer, J. Baak, 2002, Gastroenterology.

Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus

J. V. van Sandick, F. T. ten Kate, J. Baak, 2000, The Journal of pathology.

Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases.

R Montironi, P. V. van Diest, R. Montironi, 1996, Human pathology.

Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation.

R. Gentleman, Lee-Jen Wei, D. Neuberg, 2001, Gynecologic oncology.

Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.

P. V. van Diest, C. Meijer, J. Baak, 1998, Molecular pathology : MP.

Correlation of cyclin D 1 and Rb gene expression with apoptosis in invasive breast cancer

J. D. Jong, C. Meijer, J. Baak, 1998 .

An expert system for histological typing and grading of invasive breast cancer. First set up.

P. V. van Diest, J. Baak, J. Belien, 1992, Pathology, research and practice.

An evaluation of prognostic factors in advanced ovarian cancer.

G. Meijer, J. Baak, M. Brinkhuis, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas.

P. V. van Diest, J. Baak, R. Michalides, 1999, Molecular pathology : MP.

Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer.

P. V. van Diest, J. Palazzo, J. Baak, 1996, American journal of obstetrics and gynecology.

Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

P. V. van Diest, J. Baak, J. D. de Jong, 1998, The Journal of pathology.

Benign Endometrial Hyperplasia Sequence and Endometrial Intraepithelial Neoplasia

R. Bentley, S. Robboy, J. Baak, 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients.

J. Baak, C. Herman, J. Lindeman, 1989, Cytometry.

Patients with clinical/radiological hyperplasia of mammary glands show pathological persistence of temperature of skin points.

J. Baak, F. Voorhorst, Ling Zhao, 2009, Anticancer research.

Nuclear cytometric changes in breast carcinogenesis

P. V. van Diest, J. Baak, C. Meijer, 2001, The Journal of pathology.

Deoxyribonucleic acid ploidy studies in choroidal melanomas.

J. Baak, M. Leader, M. Farrell, 1993, American journal of ophthalmology.

“How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question

J. Baak, He-gen Li, Li-hua Zhu, 2021, Frontiers in Oncology.

Detection of chromosomal abnormalities by comparative genomic hybridization.

G. Meijer, J. Baak, M. Weiss, 2001, Methods in molecular biology.

Comparative genomic hybridization: a new tool in cancer pathology.

G. Meijer, J. Baak, H. Joenje, 1996, Human pathology.

Squamous morules are functionally inert elements of premalignant endometrial neoplasia

Charis Eng, Christopher P Crum, George L Mutter, 2009, Modern Pathology.

Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group

A. Moll, G. Meijer, J. Baak, 2003, Journal of clinical pathology.

Prospective Multicenter Evaluation of the Morphometric D-Score for Prediction of the Outcome of Endometrial Hyperplasias

P. V. van Diest, J. Baak, P. Kenemans, 2001, The American journal of surgical pathology.

Molecular identification of latent precancers in histologically normal endometrium.

C. Eng, J. Baak, T. Ince, 2001, Cancer research.

EIN and WHO94

J. Baak, G. Mutter, 2004, Journal of Clinical Pathology.

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

J. Baak, E. Janssen, E. Gudlaugsson, 2009, American journal of obstetrics and gynecology.

Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features.

J. Baak, P. Bezemer, E. C. Wisse-Brekelmans, 1992, Pathology, research and practice.

Number of apoptotic cells as a prognostic marker in invasive breast cancer

J. D. Jong, J. Baak, J. D. Jong, 2000, British Journal of Cancer.

LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12–21

G. Meijer, J. Baak, C. Ruivenkamp, 2003, Oncogene.

Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast‐cancer patients with long follow‐up

J. Baak, N. Schipper, H. Peterse, 1990, International journal of cancer.

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma

A. Malpica, J. Baak, E. Janssen, 2011, Modern Pathology.

Metachronous cancer development in patients with sporadic colorectal adenomas—multivariate risk model with independent and combined value of hTERT and survivin

H. Körner, K. Søreide, J. Baak, 2008, International Journal of Colorectal Disease.

The management of borderline epithelial tumors of the ovary.

J. Baak, P. Kenemans, C. Burger, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy–a feasibility study

J. Baak, P. Kurver, P. C. Diegenbach, 1981, Histopathology.

Further evaluation of quantitative nuclear image features for classification of lung carcinomas.

W Schaafsma, J. Baak, F. Thunnissen, 1992, Pathology, research and practice.

High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases

A. Malpica, J. Baak, M. Arends, 2011, Cellular Oncology.

High Frequency Microsatellite Instability Has a Prognostic Value in Endometrial Endometrioid Adenocarcinoma, But Only in FIGO Stage 1 Cases

A. Malpica, J. Baak, M. Arends, 2010, Analytical cellular pathology.

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

P. V. van Diest, J. Baak, J. D. de Jong, 1998, The Journal of pathology.

Diagnosis Making: Error Sources

J. Baak, J. Oort, F. Langley, 1983 .

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.

P. V. van Diest, L. Beex, J. Baak, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytonuclear morphometry in assesment of dysplasia in polyps Pilot study

G. Meijer, J. Baak, 1992 .

Cytonuclear morphometry in the assessment of dysplasia in colorectal adenomatous polyps. A pilot study.

G. Meijer, J. Baak, 1992, Pathology, Research and Practice.

Morphometric distinction of low- and high-grade dysplasias in gastric biopsies.

P. Barbini, J. Baak, C. Miracco, 1989, Human pathology.

TCM in Metastatic Lung Cancer: Prognosis and Complementary Treatment of Advanced Pulmonary Non-Small-Cell Lung Cancer (NSCLC)

J. Baak, C. Hempen, M. McCulloch, 2015 .

Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer

J. Baak, J. Assmus, E. Janssen, 2014, PloS one.

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer

M. Fernö, K. Lövgren, P. Bendahl, 2013, PloS one.

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers

J. Baak, E. Janssen, E. Gudlaugsson, 2012, PloS one.

Vascular proliferation is a prognostic factor in breast cancer

P. Lønning, W. Foulkes, L. Akslen, 2012, Breast Cancer Research and Treatment.

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients

J. Baak, E. Janssen, E. Gudlaugsson, 2011, Modern Pathology.

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer

A. Nysted, J. Baak, E. Janssen, 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer

J. Baak, E. Janssen, E. Gudlaugsson, 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age

Jan P. A. Baak, Emiel A. M. Janssen, J. Baak, 2009, Breast Cancer Research and Treatment.

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years

A. Nysted, J. Baak, E. Janssen, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years1

P. V. van Diest, A. Nysted, J. Baak, 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression.

J. Baak, E. Janssen, E. Gudlaugsson, 2012, Gynecologic oncology.

Origins of ... image analysis in clinical pathology.

J A Beliën, P. V. van Diest, G. Meijer, 1997, Journal of clinical pathology.

Second primary lung cancer: importance of long term follow up.

B. Corrin, J. Baak, S. Wagenaar, 1989, Thorax.

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer.

Yin-hua Yu, J. Baak, E. Janssen, 2011, Anticancer research.

Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia

E. Kuipers, G. Meijer, J. Baak, 2003, Journal of clinical pathology.

Morphometry for the prognosis of acute lymphoblastic leukemia in childhood.

A. Acquaviva, J. Baak, C. Miracco, 1987, Pathology, research and practice.

Prognostic Factors in Borderline and Invasive Ovarian Tumours of the Common Epithelial Type

J. Baak, P. Kenemans, J. Stolk, 1987 .

Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer.

J. D. Jong, J. Baak, P. Diest, 2000 .

Heterogeneity and reproducibility of microvessel counts in breast cancer.

P. V. van Diest, J. Baak, J. D. de Jong, 1995, Laboratory investigation; a journal of technical methods and pathology.

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study

J. Baak, E. Janssen, E. Gudlaugsson, 2012, Infectious Agents and Cancer.

In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!

P. V. van Diest, J. Baak, E. Janssen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.

P. V. van Diest, L. Beex, J. Baak, 2007, European journal of cancer.

In lymph node‐negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor

P. V. van Diest, J. Baak, E. Janssen, 2003, The Journal of pathology.

The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables.

M. Cuesta, J. V. van Mourik, J. Baak, 1997, Human pathology.

The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients.

P. V. van Diest, J. Baak, P. J. Diest, 1991, Human pathology.

Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.

J. Baak, J. Lindeman, J. Hermans, 1987, Journal of clinical pathology.

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer

Kjetil Søreide, Emiel A. M. Janssen, H. Körner, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours.

A. Talerman, J. Baak, J. Delemarre, 1986, Journal of clinical pathology.

Disagreement of histopathological diagnosis of different pathologists in ovarian tumors-with some theoretical considerations.

J. Baak, S. H. Overdiep, J. Lindeman, 1982, European journal of obstetrics, gynecology, and reproductive biology.

Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma.

P. V. van Diest, G. Meijer, J. Neijt, 1996, Journal of clinical pathology.

The significance of differences in prognostic value of quantitative pathologic features in FIGO stage III and IV serous adenocarcinoma of the ovary between a group of Danish patients and other groups

J. Baak, M. Brinkhuis, O. Mogensen, 1995, International Journal of Gynecologic Cancer.

Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry.

P. V. van Diest, J. Baak, J P Baak, 1990, Laboratory investigation; a journal of technical methods and pathology.

The framework of pathology: good laboratory practice by quantitative and molecular methods

J. Baak, Jan P A Baak, 2002, The Journal of pathology.

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

P. V. van Diest, J. Baak, E. Janssen, 2008, Human pathology.

Cyclin Dl Expression in Invasive Breast Cancer Correlations and Prognostic Value

J. D. Jong, C. Meijer, H. Peterse, 2007 .

Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution.

J A Beliën, P. V. van Diest, J. Baak, 1997, Cytometry.

Counting of apoptotic cells: a methodological study in invasive breast cancer

P. V. van Diest, J. Baak, J. D. de Jong, 1996, Clinical molecular pathology.

Prognostic value of morphometry in breast cancer.

P. V. van Diest, J. Baak, J. C. van der Linden, 1991, Journal of clinical pathology.

Prognostic indicators in WHO 2003 low‐grade endometrial stromal sarcoma

Yin-hua Yu, K. Hua, J. Baak, 2013, Histopathology.

In search for the best qualitative microscopical or morphometrical predictor of oestrogen receptor in breast cancer.

J. Baak, J. Persijn, 1984, Pathology, research and practice.

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.

P. V. van Diest, J. Baak, E. Bergers, 1996, Journal of clinical pathology.

UvA-DARE (Digital Academic Repository) Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparitive genomic hybridisation Hermsen,

J. Baak, F. Arwert, A. Westerveld, 2004 .

Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.

J. Baak, P. Kenemans, A. Haspels, 1996, Maturitas.

Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation.

J. Baak, H. Joenje, M. Hermsen, 1997, Oral oncology.

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3

A. Malpica, J. Baak, E. Janssen, 2011, Journal of Clinical Pathology.

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies

A. Malpica, J. Baak, E. Janssen, 2011, Proteome Science.

Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression

A. Malpica, J. Baak, E. Janssen, 2010, Modern Pathology.

Classification of New Cases: Some Aspects of Single and Multivariate Analysis

Jan P. A. Baak, F. A. Langley, J. Hermans, 1983 .

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway

J. Baak, A. Ørbo, M. Broeckaert, 2000, Journal of clinical pathology.

Reproducibility of flow cytometric assessment of follicular tumours of the thyroid.

J. Baak, P. Bezemer, M. M. van de Sandt, 1989, Journal of clinical pathology.

A multivariate morphometric analysis of the glomeruli in the normal and pathologically changed human kidney

J. Baak, H. Wehner, 2004, Virchows Archiv A.

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.

A. Malpica, J. Baak, E. Janssen, 2011, Gynecologic oncology.

P. Diest, J. Baak, R. Michalides, 2001, The Journal of pathology.

Microarray comparative genomic hybridization reveals a narrow gain at 20q13 in human gastric carcinomas

D. Pinkel, D. Albertson, E. Kuipers, 2001 .

Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study

C. J. L. M. Meijer, C. Meijer, P. Voûte, 2004, Virchows Archiv.

HETEROGENEITY OF MITOTIC ACTIVITY IN BREAST CANCER

J. Baak, B. Risberg, I. Jannink, 1996, Histopathology.

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

V. Kristensen, M. R. Aure, K. Sahlberg, 2020, BMC Cancer.

Prognostic indicators in breast cancer‐morphometric methods

M. Boon, J. Baak, P. Kurver, 1982, Histopathology.

Correlation between immunohistochemically determined oestrogen receptor content, using monoclonal antibodies, and qualitative and quantitative tissue features in ductal breast cancer

J. Baak, P. Tosi, P. Luzi, 1987, Histopathology.

Biologic profiling of lymph node negative breast cancers by means of microRNA expression

J. Baak, E. Janssen, E. Gudlaugsson, 2010, Modern Pathology.

The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer

J. Baak, J P Baak, 1985, Histopathology.

A Monotonous Population of Elongated Cells (MPECs) in Colorectal Adenoma Indicates a High Risk of Metachronous Cancer

K. Søreide, J. Baak, E. Janssen, 2006, The American journal of surgical pathology.

In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Controlled Clinical Trial

J. Baak, He-gen Li, Jia Liu, 2017, Front. Pharmacol..

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

J. Baak, E. Janssen, E. Gudlaugsson, 2012, Breast Cancer Research and Treatment.

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer

P. Diest, J. Baak, E. Janssen, 2010, Breast Cancer Research and Treatment.

Quantitative immunohistochemistry of estrogen and progesterone receptor positivity in ovarian tumors : a rapid and reliable stereological approach.

G. Meijer, J. Baak, J. Brugghe, 2001, Methods in molecular medicine.

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.

J. Baak, E. Janssen, E. Gudlaugsson, 2018, Endocrine-related cancer.

Prognostic relevance of androgen receptor detection in operable breast cancer

J. Baak, J. Varhaug, E. Janssen, 2008, Journal of surgical oncology.

Ki‐67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading

J. Baak, P. D. de Bruin, M. Jiwa, 2001, The Journal of pathology.

Nuclear Morphometry in the Determination of the Prognosis of Marked Atypical Endometrial Hyperplasia

J. Baak, J. van der Kamp, E. W. Ausems, 1985, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The Prognostic Value of Morphometry in Ovarian Epithelial Tumors of Borderline Malignancy

H. Fox, J. Baak, C. H. Buckley, 1985, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Stages I to II WHO 2003–Defined Low-Grade Endometrial Stromal Sarcoma: How Much Primary Therapy Is Needed and How Little Is Enough?

A. Malpica, K. Hua, J. Baak, 2013, International Journal of Gynecologic Cancer.

Prognostic value of morphometry and DNA flow‐cytometry features of invasive breast cancers detected by population screening: Comparison with control group of hospital patients

J. Baak, N. Schipper, H. Peterse, 1991, International journal of cancer.

The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence.

G. Tytgat, J. Baak, J. V. van Lanschot, 1995, Surgical oncology.

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

J. Baak, E. Janssen, O. Nordgård, 2011, Breast Cancer Research and Treatment.

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas

J. Baak, E. Janssen, I. Dalen, 2019, Diagnostic Pathology.

Confocal DNA cytometry: a contour-based segmentation algorithm for automated three-dimensional image segmentation.

P. V. van Diest, J. Baak, P. Tekola, 2002, Cytometry.

Reliable DNA histogram interpretation. Number of nuclei requiring measurement with flow cytometry.

P. V. van Diest, J. Baak, E. Bergers, 1997, Analytical and quantitative cytology and histology.

Morphometry of breast cancer. I. Comparison of the primary tumours and the axillary lymph node metastases.

A. Smeulders, J. Baak, J. Lindeman, 1986, Pathology, research and practice.

At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients

P. Diest, J. Baak, I. Jannink, 2004, Breast Cancer Research and Treatment.

Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

T. Postma, J. Baak, J. Lindeman, 1985, Journal of clinical pathology.

Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence.

J. Baak, E. Janssen, E. Gudlaugsson, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Molecular biomarkers in endometrial hyperplasias predict cancer progression.

A. Malpica, J. Baak, E. Janssen, 2011, American journal of obstetrics and gynecology.

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer

J. Baak, E. Janssen, E. Gudlaugsson, 2020, PloS one.

Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation.

P. V. van Diest, J. Baak, J. Fleege, 1993, Analytical and quantitative cytology and histology.

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients

J. Baak, E. Janssen, E. Gudlaugsson, 2019, PloS one.

Androgen Receptor Determination in Breast Cancer: A Comparison of the Dextran-coated Charcoal Method and Quantitative Immunohistochemical Analysis

H. Körner, J. Baak, J. Varhaug, 2008, Applied immunohistochemistry & molecular morphology : AIMM.

THREE‐DIMENSIONAL CONFOCAL LASER SCANNING DNA PLOIDY CYTOMETRY IN THICK HISTOLOGICAL SECTIONS

P. V. van Diest, J. Baak, J. Belien, 1996, The Journal of pathology.

Digital Image Analysis Improves the Quality of Subjective HER-2 Expression Scoring in Breast Cancer

Jan P. A. Baak, Emiel A. M. Janssen, J. Baak, 2008, Applied immunohistochemistry & molecular morphology : AIMM.

Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.

C. Fisher, G. Meijer, J. Baak, 1998, Gynecologic oncology.

Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder

J. Baak, E. Janssen, I. Dalen, 2014, PloS one.

Stereological assessment of architectural changes in dysplastic epithelium of colorectal adenomas.

G. Meijer, J. Baak, J. Fleege, 1994, Pathology, research and practice.

The influence of variations in the measuring procedure on quantitative nuclear image features in histologic sections of lung tissue.

J. Baak, F. Thunnissen, P. C. Diegenbach, 1988, Analytical and quantitative cytology and histology.

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer

Anais Malpica, A. Malpica, Z. Shao, 2012, Histopathology.

Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.

Weiwei Feng, Anais Malpica, A. Malpica, 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.

Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.

J. Baak, E. van der Wall, E. Janssen, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.

P. V. van Diest, J. Baak, J. Benraadt, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is the Improvement of Prognosis of Patients With Metastatic Pulmonary Adenocarcinoma Treated With TCM Herbal Medicine due to Lag Time to Treatment Bias?

J. Baak, Luming Liu, Huiru Guo, 2011, Integrative cancer therapies.

The Prognostic and Predictive Value of Syntactic Structure Analysis in Serous Carcinoma of the Ovary

J. Baak, E. Janssen, T. Rollason, 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome.

I. Shih, Tian-Li Wang, R. Kurman, 2005, Human pathology.

Syntactic structure analysis of the arrangement of nuclei in dysplastic epithelium of colorectal adenomatous polyps.

P. V. van Diest, G. Meijer, J. Baak, 1992, Analytical and quantitative cytology and histology.

Apolipoprotein D predicts adverse outcome in women ≥70 years with operable breast cancer

J. Baak, J. Varhaug, E. Janssen, 2009, Breast Cancer Research and Treatment.

Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up

J. Baak, He-gen Li, Huiru Guo, 2022, Frontiers in Oncology.

Can Proliferation Biomarkers Reliably Predict Recurrence in World Health Organization 2003 Defined Endometrial Stromal Sarcoma, Low Grade?

S. Robboy, A. Malpica, K. Hua, 2013, PloS one.

Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett’s oesophagus surveillance biopsies

G. Meijer, J. Baak, J. V. van Lanschot, 2002, Journal of clinical pathology.

Evaluation of prospective, routine application of Ki-67 immunoquantitation in early CIN for assessment of short-term progression risk.

J. Baak, E. Janssen, E. Gudlaugsson, 2004, Analytical and quantitative cytology and histology.

Malignancy-Associated Changes in Breast Tissue Detected by Image Cytometry

Jan P. A. Baak, Chris J. L. M. Meijer, P. V. van Diest, 2000, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Proposal for therapeutic approach based on prognostic factors including morphometric and flow‐cytometric features in stage iii‐iv ovarian cancer

J. Baak, J. Wils, H. Van Geuns, 1988, Cancer.

Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer: an investigation of various sampling schemes.

F. B. Sørensen, J. Baak, M. Ladekarl, 1994, Human pathology.

Standardized mitotic counts in breast cancer. Evaluation of the method.

P. V. van Diest, V. Kosma, T. Kuopio, 1996, Pathology, research and practice.

Syntactic structure analysis in invasive breast cancer: analysis of reproducibility, biologic background, and prognostic value.

P. V. van Diest, J. Baak, J P Baak, 1992, Human pathology.

Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material.

P. V. van Diest, J. Baak, E. Bergers, 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Trends in Breast Cancer Aggressiveness Before the Introduction of Mass Screening in Southeastern Netherlands 1975–1989

P. V. van Diest, J. Coebergh, J. Baak, 2002, Breast Cancer Research and Treatment.

Syntactic structure analysis in uveal melanomas.

P. V. van Diest, J. Baak, J P Baak, 1994, The British journal of ophthalmology.

Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.

P. V. van Diest, J. Baak, S. Bacus, 1991, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

P. V. van Diest, J. Baak, J. D. de Jong, 1998, The Journal of pathology.

Prognostic Value of the Diagnostic Criteria Distinguishing Endometrial Stromal Sarcoma, Low Grade From Undifferentiated Endometrial Sarcoma, 2 Entities Within the Invasive Endometrial Stromal Neoplasia Family

S. Robboy, A. Malpica, K. Hua, 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Chromosomal Instability in Pathogenesis and Prognosis of Colorectal Cancer

Academisch Proefschrift, J. Arends, G. Meijer, 2010 .

Genomics and proteomics--the way forward.

J. Baak, K. Søreide, J. Baak, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

P. V. van Diest, G. Meijer, J. Baak, 1998, The Journal of pathology.

Genomics and proteomics in cancer.

M. Hermsen, G. Meijer, J. Baak, 2003, European journal of cancer.

Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.

J. Baak, J. Baak, P. D. de Bruin, 2001, Journal of clinical pathology.

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients: An explorative study

J. Baak, K. Jonsdottir, 2020 .